Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Wiley Interdisciplinary Reviews. RNA
|
January 15, 2016
Bioengineering of noncoding RNAs for research agents and therapeutics
Pui Yan Ho, Ai-Ming Yu
Applied Microbiology and Biotechnology
|
June 13, 2019
Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs
Hannah Petrek, Neelu Batra, Pui Yan Ho, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 15, 2015
MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
Ai-Ming Yu, Ye Tian, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
June 14, 2019
Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition <i>via</i> the regulation of target ADME gene expression
Xin Li, Ye Tian, Mei-Juan Tu, et al.
Biochemical Pharmacology
|
December 28, 2020
Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth
Hannah Petrek, Pui Yan Ho, Neelu Batra, et al.
Transplantation and Cellular Therapy
|
August 22, 2022
Non-genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia
Yan Yi Chan, Pui Yan Ho, Leah Swartzrock, et al.
International Journal of Pharmaceutics
|
June 13, 2018
Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo
Qian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, et al.
Molecular Therapy. Nucleic Acids
|
February 13, 2019
Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity
Joseph L Jilek, Qian-Yu Zhang, Mei-Juan Tu, et al.
Cancer Research
|
November 8, 2019
A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells
Maxine Umeh-Garcia, Catalina Simion, Pui-Yan Ho, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Wiley Interdisciplinary Reviews. RNA
|
January 15, 2016
Bioengineering of noncoding RNAs for research agents and therapeutics
Pui Yan Ho, Ai-Ming Yu
Applied Microbiology and Biotechnology
|
June 13, 2019
Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs
Hannah Petrek, Neelu Batra, Pui Yan Ho, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 15, 2015
MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
Ai-Ming Yu, Ye Tian, Mei-Juan Tu, et al.
Acta Pharmaceutica Sinica. B
|
June 14, 2019
Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition <i>via</i> the regulation of target ADME gene expression
Xin Li, Ye Tian, Mei-Juan Tu, et al.
Biochemical Pharmacology
|
December 28, 2020
Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth
Hannah Petrek, Pui Yan Ho, Neelu Batra, et al.
Transplantation and Cellular Therapy
|
August 22, 2022
Non-genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia
Yan Yi Chan, Pui Yan Ho, Leah Swartzrock, et al.
International Journal of Pharmaceutics
|
June 13, 2018
Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo
Qian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, et al.
Molecular Therapy. Nucleic Acids
|
February 13, 2019
Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity
Joseph L Jilek, Qian-Yu Zhang, Mei-Juan Tu, et al.
Cancer Research
|
November 8, 2019
A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells
Maxine Umeh-Garcia, Catalina Simion, Pui-Yan Ho, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Page
of 3